A6888212
<i>p</i>-Acetoacetanisidide , 98% , 5437-98-9
CAS NO.：5437-98-9
Empirical Formula: C11H13NO3
Molecular Weight: 207.23
MDL number: MFCD00008783
EINECS: 226-615-6
| Pack Size | Price | Stock | Quantity |
| 25G | RMB69.60 | In Stock |
|
| 100g | RMB171.20 | In Stock |
|
| 500G | RMB448.80 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 115-118 °C |
| Boiling point: | 346.25°C (rough estimate) |
| Density | 1.1878 (rough estimate) |
| vapor pressure | 0.001Pa at 20℃ |
| refractive index | 1.5100 (estimate) |
| storage temp. | Sealed in dry,Room Temperature |
| solubility | Chloroform (Slightly), Methanol (Slightly) |
| form | Powder |
| pka | 11.35±0.46(Predicted) |
| color | White to Blue |
| Water Solubility | soluble |
| LogP | 0.85 at 23℃ and pH8.3-8.6 |
| CAS DataBase Reference | 5437-98-9(CAS DataBase Reference) |
| NIST Chemistry Reference | Butanamide, 3-oxo-n-(4-methoxyphenyl)-(5437-98-9) |
| EPA Substance Registry System | Butanamide, N-(4-methoxyphenyl)-3-oxo- (5437-98-9) |
Description and Uses
N-(4-Methoxyphenyl)-3-oxobutanamide is an intermediate in the synthesis of Tafenoquine-d3 Succinate is the labelled analog of Tatenoquine (T004760), a new 8-aminoquinoline with an improved therapeutic index and safety profile as compared to primaquine (P733500).Tafenoquine has the potential to become a widely used drug in the prevention and treatment of malaria infection and could replace some currently used drugs as resistant strains of Plasmodium species increase.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P264-P270-P301+P312+P330-P501 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| Safety Statements | 26-36/37/39 |
| RTECS | AK4598010 |
| HS Code | 2924297099 |
